Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DHB2K8
|
|||
| Drug Name |
OLX10010
|
|||
| Synonyms |
OLX 101A
Click to Show/Hide
|
|||
| Drug Type |
Small interfering RNA
|
|||
| Indication | Hypertrophic scars [ICD-11: EE60; ICD-10: L73.0] | Phase 2 | [1] | |
| Company |
Olix Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | CCN2 messenger RNA (CCN2 mRNA) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04877756) Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Olix Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.